551 related articles for article (PubMed ID: 28133804)
1. Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.
Borrow P; Moody MA
Immunol Rev; 2017 Jan; 275(1):62-78. PubMed ID: 28133804
[TBL] [Abstract][Full Text] [Related]
2. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development.
Niessl J; Kaufmann DE
Viruses; 2018 Jun; 10(6):. PubMed ID: 29921828
[TBL] [Abstract][Full Text] [Related]
3. Host controls of HIV broadly neutralizing antibody development.
Kelsoe G; Haynes BF
Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
[TBL] [Abstract][Full Text] [Related]
4. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.
Havenar-Daughton C; Lee JH; Crotty S
Immunol Rev; 2017 Jan; 275(1):49-61. PubMed ID: 28133798
[TBL] [Abstract][Full Text] [Related]
5. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
[TBL] [Abstract][Full Text] [Related]
6. Germinal center enhancement by extended antigen availability.
Cirelli KM; Crotty S
Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
[TBL] [Abstract][Full Text] [Related]
7. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.
Verkoczy L; Alt FW; Tian M
Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799
[TBL] [Abstract][Full Text] [Related]
8. Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.
Nelson AN; Goswami R; Dennis M; Tu J; Mangan RJ; Saha PT; Cain DW; Curtis AD; Shen X; Shaw GM; Bar K; Hudgens M; Pollara J; De Paris K; Van Rompay KKA; Permar SR
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092583
[TBL] [Abstract][Full Text] [Related]
9. The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses.
Moysi E; Petrovas C; Koup RA
Retrovirology; 2018 Aug; 15(1):54. PubMed ID: 30081906
[TBL] [Abstract][Full Text] [Related]
10. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.
Cohen K; Altfeld M; Alter G; Stamatatos L
J Virol; 2014 Nov; 88(22):13310-21. PubMed ID: 25210168
[TBL] [Abstract][Full Text] [Related]
11. Emerging concepts on T follicular helper cell dynamics in HIV infection.
Pissani F; Streeck H
Trends Immunol; 2014 Jun; 35(6):278-86. PubMed ID: 24703588
[TBL] [Abstract][Full Text] [Related]
12. T Cell Subsets in the Germinal Center: Lessons from the Macaque Model.
Vaccari M; Franchini G
Front Immunol; 2018; 9():348. PubMed ID: 29535724
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint modulation enhances HIV-1 antibody induction.
Bradley T; Kuraoka M; Yeh CH; Tian M; Chen H; Cain DW; Chen X; Cheng C; Ellebedy AH; Parks R; Barr M; Sutherland LL; Scearce RM; Bowman CM; Bouton-Verville H; Santra S; Wiehe K; Lewis MG; Ogbe A; Borrow P; Montefiori D; Bonsignori M; Anthony Moody M; Verkoczy L; Saunders KO; Ahmed R; Mascola JR; Kelsoe G; Alt FW; Haynes BF
Nat Commun; 2020 Feb; 11(1):948. PubMed ID: 32075963
[TBL] [Abstract][Full Text] [Related]
14. Strategies for a multi-stage neutralizing antibody-based HIV vaccine.
Andrabi R; Bhiman JN; Burton DR
Curr Opin Immunol; 2018 Aug; 53():143-151. PubMed ID: 29775847
[TBL] [Abstract][Full Text] [Related]
15. High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults.
Roider J; Maehara T; Ngoepe A; Ramsuran D; Muenchhoff M; Adland E; Aicher T; Kazer SW; Jooste P; Karim F; Kuhn W; Shalek AK; Ndung'u T; Morris L; Moore PL; Pillai S; Kløverpris H; Goulder P; Leslie A
Front Immunol; 2018; 9():1975. PubMed ID: 30258437
[TBL] [Abstract][Full Text] [Related]
16. Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.
Finney J; Kelsoe G
Retrovirology; 2018 Jul; 15(1):53. PubMed ID: 30055635
[TBL] [Abstract][Full Text] [Related]
17. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
18. Germinal centers B-cell reaction and T follicular helper cells in response to HIV-1 infection.
Jeger-Madiot R; Heredia M; Graff-Dubois S
Curr Opin HIV AIDS; 2019 Jul; 14(4):246-252. PubMed ID: 30994502
[TBL] [Abstract][Full Text] [Related]
19. Circulating CXCR5
Martin-Gayo E; Cronin J; Hickman T; Ouyang Z; Lindqvist M; Kolb KE; Schulze Zur Wiesch J; Cubas R; Porichis F; Shalek AK; van Lunzen J; Haddad EK; Walker BD; Kaufmann DE; Lichterfeld M; Yu XG
JCI Insight; 2017 Jan; 2(2):e89574. PubMed ID: 28138558
[TBL] [Abstract][Full Text] [Related]
20. Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.
Kepler TB; Wiehe K
Immunol Rev; 2017 Jan; 275(1):129-144. PubMed ID: 28133793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
